The combination of tucatinib, trastuzumab, and capecitabine is the first systemic therapy to our knowledge to demonstrate clinically meaningful benefits, including prolongation of survival, in ...
Prospective investigation of patent foramen ovale as a mechanism for brain metastasis in patients without prior lung involvement. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results